Research on chronic noncommunicable diseases in Brazil: Meeting the challenges of epidemiologic transition

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 31, Issue 3, 2012, Pages 240-245

  Moura, Erly C ^a   Pacheco Santos, Leonor M ^b   Peters, Lilian R ^c   Serruya, Suzanne J ^d   Guimarães, Reinaldo ^e  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c Ministério da Ci ncia e Tecnologia   (Brazil)

^d Centro Latino Americano de Perinatologia   (Uruguay)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Brazil; Chronic disease; Health policy; Health research policy; Health transition; Information systems

Indexed keywords

EPIDEMIOLOGY; HEALTH POLICY; HEALTH RISK; PUBLIC HEALTH; QUALITY OF LIFE; RESEARCH AND DEVELOPMENT; RISK FACTOR; SURVEILLANCE AND ENFORCEMENT;

BRAZIL;

EID: 84861369344     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892012000300009     Document Type: Article

References (23)

1. Guimarães R, Santos LM, Angulo-Tuesta A, Serruya SJ. Defining and implementing a national policy for science, technology, and innovation in health: lessons from the Brazilian experience. Cad Saude Publica. 2006;22 (4):1775-85.
2. World Health Organization. Preventing chronic diseases: a vital investment. Geneva: WHO; 2005.
3. Ministério da Saúde (BR). VIGITEL Brasil 2010: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília: MS; 2011. Available at: http://portal.saude.gov. br/portal/arqui vos/pdf/vigitel-2010-preliminar-web.pdf
4. Azambuja MI, Foppa M, Maranhão MF, Achutti AC. Impacto econômico dos casos de doença cardiovascular grave no Brasil: uma estimativa baseada em dados secundários. Arq Bras Cardiol. 2008;91 (3):148-55, 163-71.
5. Tura BR, Martino HF, Gowdak LH, dos Santos RR, Dohmann HF, Krieger JE, et al. Multicenter randomized trial of cell therapy in cardiopathies-MiHeart Study. Trials. 2007;8:2.
6. McMahon DS, Singer PA, Daar AS, Thorsteinsdóttir H. Regenerative medicine in Brazil: small but innovative. Regen Med. 2010;5 (6):863-76.
7. Instituto Nacional de Câncer (BR). Brasil terá quase meio milhão de novos casos de câncer em 2010 [press release]. Oct. 24. Rio de Janeiro: INCA; 2009. Available at: http://www.inca.gov. br/releases/press-release-view.asp?ID=2282
8. Serpieri F, Inocencio A, de Oliveira JM, Pimenta AA Jr, Garbuio A, Kalil J, et al. Comparison of humanized IgG and FvFc anti-CD3 monoclonal antibody expressed in CHO cells. Mol Biotech. 2010;45 (3):218-25.
9. Instituto Brasileiro de Geografia e Estatística (BR). Pesquisa de orçamentos familiares 2008-2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro: IBGE; 2010. Available at: http://www.ibge.gov. br/home/estatistica/popula cao/condicaodevida/pof/2008-2009-encaa/pof-20082009-encaa.pdf
10. Santos LM, de Oliveira IV, Peters LR, Conde WL. Trends in morbid obesity and in bariatric surgeries covered by the Brazilian public health system. Obes Surg. 2010;20 (7):943-8.
11. Alves JG, Gale CR, Mutrie N, Correia JB, Batty GD. A 6-month exercise intervention among inactive and overweight favela-residing women in Brazil: the Caranguejo Exercise Trial. Am J Public Health. 2009;99 (1):76-80.
12. Projeto ERICA. Estudo de Riscos Cardiovasculares em Adolescentes [homepage on the Internet]. Rio de Janeiro: Instituto de Estudos em Saúde Coletiva, Universidade Federal do Rio de Janeiro; c 2011. Available at: http://projetoerica.wordpress.com
13. Fuchs FD, Fuchs SC, Moreira LB, Gus M, Nóbrega AC, Poli-de-Figueiredo CE, et al. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVERprevention trial. Trials. 2011;12 (1):65. Available at: http://www.trialsjournal.com/con tent/12/1/65
14. Krieger EM. Multicenter trial of hypertensive patients for the identification of resistant hypertension and therapeutic standardization [abstract]. São Paulo: Instituto do Coração; 2010. Available at: http://www.bv. fapesp. br/en/projetos-politicas-publicas/7332/multicenter- trial-hypertensive-patientsidentification
15. Pinto M E B. Estimativa do número de pessoas com diabetes no Brasil em 2006: projeções de 1986-1988 a partir de mudanças demográficas e nutricionais. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2006. Available at: http://www.lume.ufrgs. br/handle/10183/8760
16. Voltarelli JC, Couri CE. Stem cell transplantation for type 1 diabetes mellitus. Diabetol Metab Syndr. 2009;1 (1):4. Available at: http://www. dmsjournal.com/content/1/1/4
17. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2009;301 (15):1573-9.
18. Moura EC, Malta DC, Morais Neto OL, Penna GO, Temporão JG. Motor vehicle driving after binge drinking, Brazil, 2006 to 2009. Rev Saude Publica. 2009;43 (5):891-4.
19. Centers for Disease Control and Prevention (US). Behavioral Risk Factor Surveillance System (BRFSS) [Internet]. Available at: http://www.cdc.gov/BRFSS
20. Monteiro CA, Moura EC, Jaime PC, Lucca A, Florindo AA, Figueiredo IC, et al. Monitoramento de fatores de risco para doenças crônicas por entrevistas telefônicas. Rev Saude Publica. 2005;39 (1):47-57. (Pubitemid 40439624)
21. Ministério da Saúde, Departamento de Ciŝncia e Tecnologia, Secretaria de Ciŝncia, Tecnologia e Insumos Estratégicos (BR). Pesquisa em saúde no Brasil. Rev Saude Publica. 2008;42 (4):773-5.
22. Maceira D, Paraje G, Aramayo F, Mais SD, Sánchez D. Financiamiento público de la investigación en salud en cinco países de América Latina. Rev Panam Salud Publica. 2010;27 (6):442-51.
23. Schooling CM, Leung GM. A socio-biological explanation for social disparities in noncommunicable chronic diseases: the product of history? J Epidemiol Community Health. 2010;64 (11):941-9.